Searched for
OTC BUSINESS
Regulatory minefield: ED enters the crypt, waking up the ghosts for Crypto IncIndia's crypto sector faces a new crisis as the Enforcement Directorate probes four firms for unauthorized foreign money transfers using di...- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Dabur shares jump 4% after Q4 results. What are Goldman Sachs, Morgan Stanley, and Nomura saying?Dabur India shares climbed 4% following strong financial results. The company reported a 15% rise in net profit for the March quarter. Reve...
- Dabur Q4 Results: Cons PAT rises 15% YoY to Rs 369 crore, revenue up 7%; Rs 5.50 per share dividend announcedDabur India reported robust fourth-quarter earnings growth driven by strong domestic FMCG demand, healthy volume expansion and broad-based ...
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- RBI finalises new risk weight normsTo be eligible, loans must be extended to individuals or small businesses with turnover up to ?500 crore, fall under standard retail produc...
- Probal Sen flags muted quarter for Reliance as O2C weakness weighsReliance Industries anticipates a subdued earnings report this quarter. The oil-to-chemicals segment faces pressure, impacting overall numb...
- Reckitt posts double-digit growth in India business for Q1Reckitt's India operations achieved double-digit growth in the first quarter of 2026. Key brands such as Dettol and Durex performed strongl...
- GST 2.0 Inverted duty structure hurts FMCG, Pharma: Expert flags concernsIndian enterprises are navigating challenges posed by the Goods and Services Tax. The inverted duty scenario is particularly affecting FMCG...
- Dr Reddy's launches heartburn drug in US marketDr Reddy's Laboratories said the combined market of Prilosec OTC and private label omeprazole OTC products had US retail sales of around $4...
- Lupin forays into OTC segment;eyes Rs 300 crore turnover in 5 yearsSoftovac's shift to OTC was piloted in West Bengal during which the brand witnessed a growth in sales of over 25 per cent, and post the suc...
- Piramal targets Rs 1,000 crore revenue in OTC business on back of buyoutsThe Mumbai-based company is on an acquisition spree and has snapped key brands from global rivals Pfizer and MSD in the last one year for a...
- Piramal Enterprises looks to buy OTC business of Morepen LaboratoriesMorepen has mandated Deloitte Touche Tohmatsu to run a formal process and the negotiations are at quite an advanced stage.
- Piramal Enterprises in talks to sell 20% stake in over-the-counter drugs businessThe group is looking to rope in a financial partner to play up its inorganic strategy of acquiring small OTC brands and businesses, said so...
- Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-croreNovartis's board approved sale of its OTC division to GSK Consumer Pvt Ltd, a consumer healthcare JV between Novartis AG & GSK, for a consi...
- Sun Pharma to push Ranbaxy's OTC brands like Revital, Volini, ChericofAccording to top executives from both the companies, Ranbaxy's OTC portfolio is going to be one of the key segments for Sun Pharma with sig...
- JB Chemicals completes sale of Russian, CIS OTC biz to J&JJBCPL said it has completed Rs 939 crore deal to sell its over-the-counter business in Russia & CIS nations to Johnson & Johnson arm Cilag ...
- OTC business showing good growth trend: Swati Piramal, Piramal HealthcareBuilding global brands and also looking at those, which have intellectual property are of top priority, says Swati Piramal, Director-Strate...
- J&J takes over Pfizer’s OTC unitThe acquisition of Pfizer’s global over-the-counter (OTC) business by Johnson & Johnson (J&J) will have some impact on Pfizer India, though...
Load More
